[Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)].Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14; 41(8):617-623.ZX
Links
Pub Type(s)
Journal Article
Practice Guideline
Language
chi
PubMed ID
32942813
Citation
Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association. "[Chinese Guideline On the Diagnosis and Management of Adult Primary Immune Thrombocytopenia (version 2020)]." Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, vol. 41, no. 8, 2020, pp. 617-623.
Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association. [Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)]. Zhonghua Xue Ye Xue Za Zhi. 2020;41(8):617-623.
Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association. (2020). [Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi, 41(8), 617-623. https://doi.org/10.3760/cma.j.issn.0253-2727.2020.08.001
Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association. [Chinese Guideline On the Diagnosis and Management of Adult Primary Immune Thrombocytopenia (version 2020)]. Zhonghua Xue Ye Xue Za Zhi. 2020 08 14;41(8):617-623. PubMed PMID: 32942813.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)].
A1 - ,,
PY - 2020/9/18/entrez
PY - 2020/9/19/pubmed
PY - 2021/2/2/medline
SP - 617
EP - 623
JF - Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
JO - Zhonghua Xue Ye Xue Za Zhi
VL - 41
IS - 8
SN - 0253-2727
UR - https://www.unboundmedicine.com/medline/citation/32942813/
DB - PRIME
DP - Unbound Medicine
ER -

